Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3NIH 1FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 4399Urinary Bladder Neoplasms 1078Carcinoma, Renal Cell 1041Kidney Neoplasms 567Breast Neoplasms 453Neoplasms 403Carcinoma, Transitional Cell 299Neoplasm Metastasis 250Lung Neoplasms 242Testicular Neoplasms 202Melanoma 195Colorectal Neoplasms 193Ovarian Neoplasms 163Carcinoma, Non-Small-Cell Lung 150Sarcoma 135Non-Muscle Invasive Bladder Neoplasms 135Pancreatic Neoplasms 124Colonic Neoplasms 121Head and Neck Neoplasms 116Uterine Cervical Neoplasms 115Wilms Tumor 108Recurrence 106Motor Activity 100Stomach Neoplasms 89Urologic Neoplasms 88Neuroblastoma 88Disease 85Multiple Myeloma 83Carcinoma, Hepatocellular 79Adenocarcinoma 79

Interventions

Multiparametric Magnetic Resonance Imaging 1Exome 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Prostate cancer, familial × Genitourinary × Clear all
NCT07416812 2026-02-18

IMPACT

Institute of Oncology Ljubljana

Phase NA Completed
25 enrolled
Genitourinary

Prostate cancer, familial, Prostatic Neoplasms, Genetic Predisposition to Disease

NCT05681416 2023-01-12

ProFam-Risk

Heinrich-Heine University, Duesseldorf

Phase NA Not yet recruiting
300 enrolled
Genitourinary

Prostate cancer, familial, Prostatic Neoplasms, Genetic Predisposition to Disease

NCT02381015 2019-11-22

Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a

Endeavor Health

Phase NA Completed
700 enrolled 13 charts
Genitourinary

Prostate cancer, familial, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡